These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 22781793

  • 21. [Reversed effect of valproic acid on transcription inhibition of AML1-ETO fusion protein of kasumi-1 leukemic cell line].
    Zhao L, Zhu CM, Zhang ZH, Tian WL, Hao CL.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):363-7. PubMed ID: 19379567
    [Abstract] [Full Text] [Related]

  • 22. Honokiol induces proteasomal degradation of AML1-ETO oncoprotein via increasing ubiquitin conjugase UbcH8 expression in leukemia.
    Zhou B, Li H, Xing C, Ye H, Feng J, Wu J, Lu Z, Fang J, Gao S.
    Biochem Pharmacol; 2017 Mar 15; 128():12-25. PubMed ID: 28043811
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The novel inhibitor of histone deacetylase resminostat (RAS2410) inhibits proliferation and induces apoptosis in multiple myeloma (MM) cells.
    Mandl-Weber S, Meinel FG, Jankowsky R, Oduncu F, Schmidmaier R, Baumann P.
    Br J Haematol; 2010 May 15; 149(4):518-28. PubMed ID: 20201941
    [Abstract] [Full Text] [Related]

  • 25. Epigenetic Silencing of Eyes Absent 4 Gene by Acute Myeloid Leukemia 1-Eight-twenty-one Oncoprotein Contributes to Leukemogenesis in t(8;21) Acute Myeloid Leukemia.
    Huang S, Jiang MM, Chen GF, Qian K, Gao HH, Guan W, Shi JL, Liu AQ, Liu J, Wang BH, Li YH, Yu L.
    Chin Med J (Engl); 2016 Jun 05; 129(11):1355-62. PubMed ID: 27231175
    [Abstract] [Full Text] [Related]

  • 26. Butyrates and decitabine cooperate to induce histone acetylation and granulocytic maturation of t(8;21) acute myeloid leukemia blasts.
    Gozzini A, Santini V.
    Ann Hematol; 2005 Dec 05; 84 Suppl 1():54-60. PubMed ID: 16228241
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. ZFP36L2, a novel AML1 target gene, induces AML cells apoptosis and inhibits cell proliferation.
    Liu J, Lu W, Liu S, Wang Y, Li S, Xu Y, Xing H, Tang K, Tian Z, Rao Q, Wang M, Wang J.
    Leuk Res; 2018 May 05; 68():15-21. PubMed ID: 29518627
    [Abstract] [Full Text] [Related]

  • 31. Oroxylin A, a natural anticancer flavonoid compound, induces differentiation of t(8;21)-positive Kasumi-1 and primary acute myeloid leukemia cells.
    Hui H, Zhang X, Li H, Liu X, Shen L, Zhu Y, Xu J, Guo Q, Lu N.
    J Cancer Res Clin Oncol; 2016 Jul 05; 142(7):1449-59. PubMed ID: 27085528
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Superior activity of a new histone deacetylase inhibitor (ZYJ-34c) in inhibiting growth of human leukemia cells by inducing p21WAF1 expression and cell cycle arrest.
    Yang H, Xu W, Li Y, Lan P, Zhang J, Zhang Y, Zhang C.
    Anticancer Drugs; 2014 Aug 05; 25(7):767-77. PubMed ID: 24686006
    [Abstract] [Full Text] [Related]

  • 34. ITF2357 interferes with apoptosis and inflammatory pathways in the HL-60 model: a gene expression study.
    Galimberti S, Canestraro M, Savli H, Palumbo GA, Tibullo D, Nagy B, Piaggi S, Guerrini F, Cine N, Metelli MR, Petrini M.
    Anticancer Res; 2010 Nov 05; 30(11):4525-35. PubMed ID: 21115902
    [Abstract] [Full Text] [Related]

  • 35. Identification of AML1-ETO modulators by chemical genomics.
    Corsello SM, Roti G, Ross KN, Chow KT, Galinsky I, DeAngelo DJ, Stone RM, Kung AL, Golub TR, Stegmaier K.
    Blood; 2009 Jun 11; 113(24):6193-205. PubMed ID: 19377049
    [Abstract] [Full Text] [Related]

  • 36. [Combination of phenylbutyrate and 5-Aza-2'deoxycytidine inhibits human Kasumi-1 xenograft tumor growth in nude mice].
    Hao CL, Lin D, Wang LH, Xing HY, Wang M, Wang JX.
    Zhonghua Xue Ye Xue Za Zhi; 2004 Nov 11; 25(11):658-61. PubMed ID: 15634569
    [Abstract] [Full Text] [Related]

  • 37. AML1/ETO-induced survivin expression inhibits transcriptional regulation of myeloid differentiation.
    Balkhi MY, Christopeit M, Chen Y, Geletu M, Behre G.
    Exp Hematol; 2008 Nov 11; 36(11):1449-60. PubMed ID: 18687517
    [Abstract] [Full Text] [Related]

  • 38. The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner.
    Elsässer A, Franzen M, Kohlmann A, Weisser M, Schnittger S, Schoch C, Reddy VA, Burel S, Zhang DE, Ueffing M, Tenen DG, Hiddemann W, Behre G.
    Oncogene; 2003 Aug 28; 22(36):5646-57. PubMed ID: 12944913
    [Abstract] [Full Text] [Related]

  • 39. Melatonin promotes differentiation and apoptosis of AML1-ETO-positive cells.
    Liu X, Sun W, Wang L, Zhou B, Li P.
    Bull Cancer; 2023 Apr 28; 110(4):342-351. PubMed ID: 36863921
    [Abstract] [Full Text] [Related]

  • 40. Effect of trichostatin A, a histone deacetylase inhibitor, on glioma proliferation in vitro by inducing cell cycle arrest and apoptosis.
    Wetzel M, Premkumar DR, Arnold B, Pollack IF.
    J Neurosurg; 2005 Dec 28; 103(6 Suppl):549-56. PubMed ID: 16383255
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.